CLINICAL_TRIALS
trial_result
· 2021-07-09
Clinical Trial Update: β-RELIEVED - REsponse in Acute fLare and In prEVEntion of episoDes of Re-flare in Gout - Extension 3 (E3) [Phase 3]
Summary
Phase 3 extension study update for a gout flare treatment (β-RELIEVED) completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Acute Gouty Arthritis Flares | Phase 3 | Status: COMPLETED | Results posted: 2021-07-09